Inventor · disambiguated record
Kent B. Thudium
Also filed as: THUDIUM KENT · THUDIUM KENT B
28 granted patents·10 pending applications·595 citations·filing 1994–2025
97Inventor score
Files withSQUIBB & SONS LLC14CHIRON CORP8BRISTOL MYERS SQUIBB CO4NOVARTIS VACCINES & DIAGNOSTIC4KORMAN ALAN1
Top patents by PatentIndex Score
38 records- 0198US11001630B2Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2020·Granted May 11, 2021·10 cites·20 claims
- 0298US10988536B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2020·Granted Apr 27, 2021·10 cites·20 claims
- 0398US10344089B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2017·Granted Jul 9, 2019·25 cites·20 claims
- 0497US11530267B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Dec 20, 2022·2 cites·21 claims
- 0597US11236165B2Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Feb 1, 2022·4 cites·21 claims
- 0697US11236163B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Feb 1, 2022·4 cites·21 claims
- 0797US11236164B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Feb 1, 2022·4 cites·21 claims
- 0896US11512130B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2021·Granted Nov 29, 2022·2 cites·22 claims
- 0996US10988535B2Human antibodies that bind lymphocyte activation gene-3 (LAG-3), and uses thereofSQUIBB & SONS LLC·Filed 2019·Granted Apr 27, 2021·10 cites·20 claims
- 1096US8263073B2Anti-CTLA-4 antibodies with reduced blocking of binding of CTLA-4 to B7 and uses thereofKORMAN ALAN·Filed 2009·Granted Sep 11, 2012·50 cites·4 claims
- 1195US9644032B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2016·Granted May 9, 2017·12 cites·30 claims
- 1293US8563694B2Fully human antibodies to BTLAMATARAZA JENNIFER MARIE·Filed 2010·Granted Oct 22, 2013·39 cites·8 claims
- 1393US7572453B2Chimeric alphavirus replicon particlesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2006·Granted Aug 11, 2009·18 cites·23 claims
- 1493US7105303B2Antibodies to hepatitis C virus asialoglycoproteinsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2001·Granted Sep 12, 2006·44 cites·15 claims
- 1591US9255126B2Chimeric alphavirus replicon particlesPOLO JOHN M·Filed 2009·Granted Feb 9, 2016·20 cites·20 claims
- 1691US5942234AHepatitis C virus asialoglycoproteinsCHIRON CORP·Filed 1995·Granted Aug 24, 1999·74 cites·27 claims
- 1790US6274148B1Hepatitis C virus asialoglycoproteinsCHIRON CORP·Filed 1994·Granted Aug 14, 2001·55 cites·25 claims
- 1888US9346882B2Fully human antibodies to BTLAMEDAREX LLC·Filed 2013·Granted May 24, 2016·9 cites·22 claims
- 1988US8158418B2Chimeric alphavirus replicon particlesPOLO JOHN·Filed 2009·Granted Apr 17, 2012·13 cites·11 claims
- 2088US7531180B2Chimeric alphavirus replicon particlesNOVARTIS VACCINES & DIAGNOSTIC·Filed 2002·Granted May 12, 2009·15 cites·55 claims
- 2188US6074846AHepatitis C virus asialoglycoproteinsCHIRON CORP·Filed 1995·Granted Jun 13, 2000·61 cites·9 claims
- 2288US6074852AHepatitis C virus asialoglycoproteinsCHIRON CORP·Filed 1995·Granted Jun 13, 2000·53 cites·11 claims
- 2386US2023322919A1Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), and Uses ThereofSQUIBB & SONS LLC·Filed 2022·Application pending·0 cites
- 2483US11466092B2Antibodies against OX-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Oct 11, 2022·1 cites·19 claims
- 2583US6893840B2Cytomegalovirus Intron A fragmentsCHIRON CORP·Filed 2001·Granted May 17, 2005·9 cites·17 claims
- 2681US10683357B2Antibodies against OX40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jun 16, 2020·1 cites·19 claims
- 2781US7846687B2Cytomegalovirus Intron A fragmentsNOVARTIS VACCINES & DIAGNOSTIC·Filed 2005·Granted Dec 7, 2010·3 cites·4 claims
- 2880US6096505ANoncloning technique for expressing a gene of interestCHIRON CORP·Filed 1999·Granted Aug 1, 2000·47 cites·36 claims
- 2980US2025154254A1Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereofSQUIBB & SONS LLC·Filed 2025·Application pending·0 cites
- 3078US2023272100A1Antibodies against ox-40 and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 3174US2020231671A1Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereofSQUIBB & SONS LLC·Filed 2019·Application pending·0 cites
- 3272US2011150892A1Human antibodies that bind lymphocyte activation gene-3 (lag-3) and uses thereofMEDAREX INC·Filed 2009·Application pending·0 cites
- 3365US2008318275A1Hepatitis C virus asialoglycoproteinsRALSTON ROBERT O·Filed 2008·Application pending·0 cites
- 3460US2005089843A1Antibodies to hepatitis C virus asialoglycoproteinsCHIRON CORP·Filed 2004·Application pending·0 cites
- 3559US2019119381A1Fully human antibodies to btlaSQUIBB & SONS LLC·Filed 2018·Application pending·0 cites
- 3657US2003232324A1Chimeric alphavirus replicon particlesCHIRON CORP·Filed 2002·Application pending·0 cites
- 3756US10155813B2Fully human antibodies to BTLASQUIBB & SONS LLC·Filed 2016·Granted Dec 18, 2018·0 cites·4 claims
- 3840US2012100573A1Cytomegalovirus intron a fragmentsTHUDIUM KENT B·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →